X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (358) 358
Book Chapter (38) 38
Book / eBook (11) 11
Patent (9) 9
Web Resource (5) 5
Magazine Article (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (228) 228
male (145) 145
pathology (144) 144
female (138) 138
middle aged (114) 114
adult (102) 102
aged (87) 87
immunohistochemistry (62) 62
aged, 80 and over (54) 54
hematology (53) 53
adolescent (48) 48
immunophenotyping (42) 42
diagnosis (38) 38
expression (38) 38
classification (35) 35
oncology (35) 35
bone marrow (34) 34
child (34) 34
surgery (34) 34
leukemia (33) 33
flow cytometry (32) 32
acute myeloid leukemia (28) 28
prognosis (28) 28
abridged index medicus (27) 27
mutation (26) 26
child, preschool (25) 25
young adult (25) 25
retrospective studies (24) 24
polymerase chain reaction (23) 23
bone marrow - pathology (22) 22
diagnosis, differential (22) 22
medical laboratory technology (22) 22
translocation, genetic (22) 22
disease (21) 21
biopsy (20) 20
in situ hybridization, fluorescence (20) 20
tumors (20) 20
cytogenetics (19) 19
leukemia, myeloid, acute - genetics (19) 19
acute myeloid-leukemia (17) 17
karyotyping (17) 17
acute lymphoblastic-leukemia (16) 16
mutations (16) 16
non-hodgkins-lymphoma (16) 16
biomarkers, tumor - metabolism (15) 15
features (15) 15
infant (15) 15
acute disease (14) 14
animals (14) 14
cancer (14) 14
chromosome aberrations (14) 14
hemic and lymphatic diseases (14) 14
lymphoma (14) 14
medicine, research & experimental (14) 14
myelodysplastic syndromes (14) 14
myelodysplastic syndromes - genetics (14) 14
phenotype (14) 14
t (14) 14
aml (13) 13
lymphoma, b-cell - pathology (13) 13
world health organization (13) 13
antigens, cd - analysis (12) 12
biomarkers, tumor - analysis (12) 12
leukemia, myeloid, acute - pathology (12) 12
lymphomas (12) 12
neoplasms (12) 12
dna mutational analysis (11) 11
gene rearrangement (11) 11
leukemia, myeloid - genetics (11) 11
leukemia, myeloid, acute - diagnosis (11) 11
lymph nodes - pathology (11) 11
myelodysplastic syndrome (11) 11
myelodysplastic syndromes - pathology (11) 11
paraffin embedding (11) 11
prognostic-significance (11) 11
survival (11) 11
acute promyelocytic leukemia (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
children (10) 10
diseases (10) 10
follow-up studies (10) 10
hygiene (10) 10
immunoglobulin heavy chains - genetics (10) 10
research (10) 10
united states (10) 10
analysis (9) 9
bandages, dressings or absorbent pads (9) 9
blood (9) 9
case-control studies (9) 9
chronic myelomonocytic leukemia (9) 9
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (9) 9
differentiation (9) 9
disease-free survival (9) 9
electrotherapy (9) 9
filters implantable into blood vessels (9) 9
first-aid kits (9) 9
fomentation (9) 9
genetic aspects (9) 9
human necessities (9) 9
leukemia, myeloid - pathology (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern pathology, ISSN 1530-0285, 2012, Volume 25, Issue 8, pp. 1128 - 1139
...  Modern Pathology (2012) 25, 11281139 1128 & 2012 USCAP, Inc. All rights reserved 0893-3952/12 $32.00 Daniel T Chang1,*, Rish K Pai2,*, Lisa A Rybicki3... 
signet ring | colorectal carcinoma | early-onset | MICROSATELLITE INSTABILITY | RISK | YOUNG-PATIENTS | PATHOLOGY | COLON-CANCER | SERRATED POLYPS | BRAF MUTATION | METHYLATOR PHENOTYPE | CARCINOMA | PAPILLOMAVIRUS INFECTION | ADENOMAS | ras Proteins - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Adenoma - epidemiology | Adenoma - genetics | Rectum - pathology | Carcinoma, Signet Ring Cell - metabolism | Colon, Sigmoid - surgery | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Carcinoma, Signet Ring Cell - genetics | Colon, Sigmoid - metabolism | Adenoma - metabolism | DNA-Binding Proteins - metabolism | Young Adult | Adenocarcinoma - metabolism | DNA Mismatch Repair | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | MutS Homolog 3 Protein | Adenocarcinoma - genetics | Rectum - surgery | Colon, Sigmoid - pathology | Colorectal Neoplasms - metabolism | Colorectal Neoplasms - epidemiology | Carcinoma, Signet Ring Cell - pathology | California - epidemiology | Rectum - metabolism | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Carcinoma, Signet Ring Cell - epidemiology | Proto-Oncogene Proteins B-raf - genetics | Adolescent | Age of Onset | Adenoma - pathology | Aged | Biomarkers, Tumor - genetics | Mutation | Adenocarcinoma - epidemiology | Colorectal Neoplasms - pathology
Journal Article
Human Pathology, ISSN 0046-8177, 2016, Volume 55, pp. 39 - 43
Summary Histiocytic sarcoma is rare and difficult to distinguish from histologic mimics such as myeloid sarcoma due to its relatively nonspecific... 
Pathology | Follicular lymphoma | BCL2 | Monocytic differentiation | Myeloid sarcoma | Histiocytic sarcoma | GENE REARRANGEMENTS | FREQUENCY | ACUTE MYELOID-LEUKEMIA | CELL SARCOMAS | PATHOLOGY | EXPRESSION | TRANSDIFFERENTIATION | Immunohistochemistry | Lymphoma, Follicular - chemistry | Translocation, Genetic | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Muscle Neoplasms - pathology | Male | Histiocytic Sarcoma - therapy | Liver Neoplasms - therapy | Bone Marrow Neoplasms - genetics | Liver Neoplasms - chemistry | Genes, Immunoglobulin Heavy Chain | Lymphoma, Large B-Cell, Diffuse - therapy | Muscle Neoplasms - therapy | Lymphoma, Follicular - genetics | Time Factors | Muscle Neoplasms - genetics | Lymphoma, Large B-Cell, Diffuse - chemistry | Female | Histiocytic Sarcoma - genetics | Liver Neoplasms - pathology | Histiocytic Sarcoma - pathology | Bone Marrow Neoplasms - chemistry | Bone Marrow Neoplasms - therapy | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Gene Fusion | In Situ Hybridization, Fluorescence | Bone Marrow Examination | Phenotype | Bone Marrow Neoplasms - pathology | Biopsy | Muscle Neoplasms - chemistry | Aged | Biomarkers, Tumor - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Sarcoma | Lymphomas | Bone marrow | Flow cytometry | Population | Leukemia
Journal Article
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 03/2017, Volume 24, Issue 2, pp. 146 - 151
Journal Article
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 05/2012, Volume 36, Issue 5, pp. 744 - 752
Journal Article
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 10/2015, Volume 21, Issue 35, pp. 5127 - 5134
Journal Article
Modern pathology, ISSN 1530-0285, 2018, Volume 31, Issue 5, pp. 690 - 704
... Craig R Soderquist1,9, Mark D Ewalt2, David R Czuchlewski3, Julia T Geyer4, Heesun J Rogers5, Eric D Hsi5, Sa A Wang6, Carlos E Bueso-Ramos6, Attilio Orazi4, Daniel... 
CHRONIC MYELOGENOUS LEUKEMIA | POLYCYTHEMIA-VERA | JAK2(V617F) MUTATION | BCR-ABL TRANSLOCATION | IMATINIB | PATIENT | JAK2V617F MUTATION | PATHOLOGY | ESSENTIAL THROMBOCYTHEMIA | CHRONIC MYELOID-LEUKEMIA | JAK2-V617F MUTATION | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Primary Myelofibrosis - pathology | Bone Marrow Neoplasms - genetics | Myeloproliferative Disorders - genetics | Primary Myelofibrosis - blood | Myeloproliferative Disorders - blood | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Fusion Proteins, bcr-abl - blood | Aged, 80 and over | Female | Retrospective Studies | Janus Kinase 2 - antagonists & inhibitors | Primary Myelofibrosis - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Bone Marrow Neoplasms - blood | Enzyme Inhibitors - therapeutic use | Disease Progression | Fusion Proteins, bcr-abl - genetics | Primary Myelofibrosis - genetics | Bone Marrow Neoplasms - pathology | Multi-Institutional Systems | Bone Marrow - pathology | Fusion Proteins, bcr-abl - antagonists & inhibitors | Aged | Bone Marrow Neoplasms - drug therapy | Mutation | Janus Kinase 2 - blood | Tyrosine | BCR protein | Myelofibrosis | Myeloid leukemia | Chronic myeloid leukemia | Kinases | Hematopoietic stem cells | Disease resistance | Janus kinase 2 | Stem cells | Bone marrow | Protein-tyrosine kinase | Tumors | Hemopoiesis
Journal Article